University of California, Berkeley
Appointed in 1958
Read more
University of California, Berkeley
Appointed in 1958
Cofactor invocled in glutamate fermentation by Clostridium tetanomorphum as a Viatamin B12 derivative
Harvard University Medical School
Appointed in 2003
Read more
Harvard University Medical School
Appointed in 2003
Dissection of innate immunity in C elegans
Institut Pasteur, France
Appointed in 1995
Role for phosphoinositide 3-kinase in bacterial invasion
University of Cambridge, England /
Yale University
Appointed in 1986
Read more
University of Cambridge, England / Yale University
Appointed in 1986
Genetic and molecular basis of positional specification
Stanford University
Appointed in 1983
DNA sequencing
Vanderbilt University Medical Center
Appointed in 2025
Read more
Vanderbilt University Medical Center
Appointed in 2025
Defining the targets of the antibody response to natural Oropouche virus infection
Dr. Hannah Itell’s passion for understanding the “ever-evolving virus-host arms race” started during her undergraduate global health studies in India, South Africa, and Brazil. Seeing the impact of viral infection on individuals, families, communities, and entire countries, motivated Itell to dedicate her research career to preventing viral transmission.
In her graduate research in Dr. Julie Overbaugh’s lab at the Fred Hutchinson Cancer Center, Itell focused on identifying human traits that limit HIV severity. She discovered that many virus-fighting genes seen in lab-grown cells function differently than real human immune cells,, demonstrating that common lab models may not reflect what really happens in the body. Next, she identified a gene that regulates a pattern in HIV transmission that was not previously understood.
Now as a Fellow in Dr. Ivelin Georgiev’s lab at Vanderbilt, Itell has switched her focus to the Oropouche virus which is endemic to Brazil.There are currently no vaccines or specific treatments available to prevent or treat infection. Itell will find out how many virus types can be blocked by antibodies and where on the virus the antibodies attach. Itell’s efforts will provide fundamental knowledge about host response to Oropouche virus and directly inform rational vaccine design in the development of antibody therapeutics.
Harvard University Medical School
Appointed in 2007
Read more
Harvard University Medical School
Appointed in 2007
Roles of a histone demethylase SMCX in neuronal function
Harvard University
Appointed in 1972
Structure of spherical viruses
Harvard University
Appointed in 1979
Molecular basis of transvection in Drosophila
University of Massachusetts Medical School
Appointed in 1975
Read more
University of Massachusetts Medical School
Appointed in 1975
Regulation of slime mold mRNA synthesis
Boston Children's Hospital
Appointed in 2020
Somatosensory control of barrier tissue immunity
Advancements in vaccine design and immunotherapy have helped us gain insights into how to promote immunity against infections or cancers. However, excessive inflammation associated with immunotherapies, autoimmune diseases, non-healing wounds and even COVID19 is currently at the center of healthcare challenges. Following an inflammatory insult, such as an injury or pathogen invasion, immune cells in the tissues are crucial to resolve inflammation and regain healthy tissue function. Damaging inflammatory signals also activate nearby high threshold sensory neurons– the nociceptors – which are responsible for initiating pain and guarding/withdrawal responses which is believed to prevent further tissue damage. While it is conceivable that nociceptors can cooperate with immune to promote healing, the role of these neurons in shaping the healthy immune landscape of barrier tissues is currently unexplored. In the Woolf lab, I aim to determine the role of nociceptor sensory neurons in restoring the healthy immune profile of barrier tissues following an adverse and painful inflammatory event and develop novel strategies to manipulate neuroimmune interactions using genetic and pharmacological methods. Traditionally, inflammatory conditions are treated with broad immunosuppressants that put the patients at risk for further infections. The ability to fine tune immune function by controlling specific neuronal signals will offer a safer and effective therapeutic strategy for various inflammatory diseases as well as malignancies.
Rockefeller University
Appointed in 2003
Mechanism of transcription activiation
University of California, Los Angeles
Appointed in 2016
Read more
University of California, Los Angeles
Appointed in 2016
Deep mutational suppressor screens to uncover splicing mechanisms and coding constraints
The mitochondrion is a subcellular organelle that is the center of energy production, calcium signaling, apoptosis and redox balance for the cell. Therefore, many diseases and normal aging run their molecular course through the mitochondrion. Uniquely, the mitochondrion contains its own DNA and makes RNA and proteins independently from the rest of the cell. This orthogonal system had presented a problem for studying the mitochondrion as the usual genetic tools of the nuclear genome are not available. However, I am using the tools of synthetic biology to allow specific interrogation of mitochondrial protein synthesis in healthy and diseased human cells._x000D_
_x000D_
In addition to studying mitochondrial protein synthesis, I am developing the yeast mitochondrion as a platform for synthetic biology in order to greatly expand the genetic code and to speed up laboratory evolution. These tools will allow creation of novel therapeutic biopolymers and proteins.
University of California, San Francisco
Appointed in 1983
Read more
University of California, San Francisco
Appointed in 1983
Construction of hormone modulated transformed cells
Stanford University
Appointed in 1984
Homing mechanisms of normal and malignant lymphocytes
University of Wisconsin, Madison
Appointed in 1990
Read more
University of Wisconsin, Madison
Appointed in 1990
Multiple protein tyrosine phosphatase genes from the yeast S. cerevisiae
University of California, San Francisco
Appointed in 2008
Read more
University of California, San Francisco
Appointed in 2008
Defining the role of the actin cytoskeleton in plasma membrane organization during T-cell activation
My research involves the reconstruction of the T-cell antigen receptor signaling pathway in an orthogonal cell line to piece apart the molecular details of immune cell triggering, and how the system’s specificity and sensitivity can be genetically encoded.
I am originally from England and did both my undergraduate biochemistry degree and doctoral work at the University of Oxford. Throughout this period, my thoughts became increasingly focused on how signals are transmitted across the impermeable cell membrane, especially where the receptor responsible has no enzymatic activity of its own. For me, this area of research combines cell biology, biochemistry and systems analysis into one very exciting topic which, when applied to cells of the immune system, can have clear implications for new points of therapeutic intervention. Relocating to San Francisco for my postdoc has also provided me with great insights into the similarities and differences between approaches to scientific research on opposite sides of the Atlantic. I hope to combine the best of both worlds when starting my independent career in the near future.
Yale University
Appointed in 1979
Gene expression
Stanford University
Appointed in 2010
Elucidating the molecular basis of canonical Wnt signaling activation and inhibition at the cell surface
Working in the lab of K. Christopher Garcia, I am studying the assembly and three-dimensional structures of Wnt-receptor complexes in order to understand Wnt signaling mechanisms, and facilitate development of new strategies to clinically target Wnt-associated diseases.
I have always enjoyed studying biological problems, particularly using structural and biochemical methods to understand underlying molecular mechanisms.  I am most fascinated by fundamental and hard problems that require creativity, tenacity and dedication to solve.  After having studied fundamental aspects of protein translocation, I now wish to examine receptor-ligand interactions with high relevance to human disease. Wnt signaling is important in many developmental and regenerative processes, and in a variety of human diseases, including many types of cancers. However, due to major technical difficulties, there is a complete lack of extracellular structural information about Wnt signaling activation and inhibition. We are using traditional and novel methodologies to obtain structural information that can ultimately facilitate the development of new strategies to therapeutically target Wnt signaling. Most of my spare time is spent running over the hills behind Stanford to train for a marathon, relax from hard work, and think about new ways to approach scientific problems.
Stanford University
Appointed in 1985
Homologous recombination in mammalian cells
University of California, Berkeley
Appointed in 1968
Read more
University of California, Berkeley
Appointed in 1968
Interactions of proteins with nucleic acids
Montefiore Hospital
Appointed in 1961
Metabolism of hemoglobin
Columbia University
Appointed in 1971
Incorporation of adenovirus into the host DNA of transformed cells
Cold Spring Harbor Laboratory
Appointed in 1971
Read more
Cold Spring Harbor Laboratory
Appointed in 1971
SV40 DNA and SV40 messenger RNA
Columbia University
Appointed in 2017
Read more
Columbia University
Appointed in 2017
Microbial adaptation to extreme environments facilitated by CRISPR-Cas
The genetic diversity within microbial populations provides important means for the organisms to survive in fluctuating environments. Studying such diversity helps to elucidate how mutations within population interact with each other, and how the host microbes harboring them adapt and evolve to extreme environments such the presence of antibiotics. Although whole genome sequencing can readily detect all mutations at a population level, methods that can quantify the abundance of mutations at both the population and single-cell resolution are lacking. Here I propose to implement a CRISPR-Cas system that works as both a transcriptional perturbation and a molecular recording device in bacteria. This technology can rapidly and continuously generate highly diverse knock-down variants among a microbial population_x000D_
while it is adapting to extreme environments that pose significant fitness challenges. Combined with deep sequencing of the CRISPR “memory cassette”, the transcriptional perturbation and the evolutionary trajectories in each individual cells of the population can be quantified and followed, respectively. Results_x000D_
obtained from this method can also shed light on epistatic interactions and contingencies between mutations, and reveal novel regulatory pathways that are important for antibiotic resistance.
Massachusetts Institute of Technology
Appointed in 1991
Read more
Massachusetts Institute of Technology
Appointed in 1991
Neuronal cell differentiation
University of California, San Francisco
Appointed in 1993
Read more
University of California, San Francisco
Appointed in 1993
AP-1 factors in mouse models of tumorigenesis
California Institute of Technology
Appointed in 1996
Read more
California Institute of Technology
Appointed in 1996
Yeast mRNA splicing
Rockefeller University
Appointed in 1971
Chromosome structure
Albert Einstein College of Medicine
Appointed in 1972
Read more
Albert Einstein College of Medicine
Appointed in 1972
Role of protein phosphorylation in tumor virus infection
University of California, San Francisco
Appointed in 2014
Read more
University of California, San Francisco
Appointed in 2014
Mechanisms of VCP-mediated cellular degeneration
Rockefeller University
Appointed in 2016
Structural and mechanistic studies of multidrug resistance mediated by MRP1
Resistance to chemotherapeutic drugs is a major obstacle in the successful treatment of many different forms of cancer. This so-called multidrug resistance is often mediated by a class of proteins known as ABC transporters. These proteins reside in the plasma membrane and actively pump molecules out of the cell by utilizing the energy of ATP binding and hydrolysis. Some ABC transporters recognize and extrude anticancer compounds before they are able to kill the cancer cells, leading to drug resistance and treatment failure._x000D_
_x000D_
My project seeks to gain a better mechanistic understanding of these transporters and their role in multidrug resistance by utilizing a combination of structural and functional studies. My focus will be on the ABC transporter known as multidrug resistance protein 1 (MRP1). If we can better understand how these proteins are able to recognize and transport their drug substrates, we will be able to develop ways to block or circumvent their function during cancer treatment. If successful, these studies will not only further our knowledge of ABC transporter biology, but they will also lay a framework for combating multidrug resistance in cancer patients.
New York University
Appointed in 2006
Stochastic fate choice generating the retinal mosaic
University of California, Berkeley
Appointed in 1976
Read more
University of California, Berkeley
Appointed in 1976
Yeast mating pheromones: their mechanism of action
Harvard University Medical School
Appointed in 2005
Read more
Harvard University Medical School
Appointed in 2005
Vertebrate growth control in a developmental context
California Institute of Technology
Appointed in 1992
Read more
California Institute of Technology
Appointed in 1992
GAL6-A DNA-binding protease
New York University
Appointed in 2000
Role of nodal signaling during gastrulation
Harvard University
Appointed in 2019
Genetic and neural basis of natural variation in infant vocalization
Infant vocalization is a pervasive mammalian social behavior that elicits parental care essential for infant health. Features of infant vocalization are innate, heritable, and vary between species, but we know little about the genetic or neural mechanisms underlying this variation. To better understand these mechanisms, I study the cries of infant Peromyscus mice (also known as deer mice), a group of closely related rodents that have recently diversified across North America and evolved a range of heritable behaviors. Deer mice are attractive systems to understand natural variation in infant vocal behaviors because interfertile species exhibit infant cries that differ in their spectral and temporal features, opening the possibility to map the genetic basis of natural variation in these features. Using approaches from neuroscience, genetics, and ethology, my work aims to make explicit mechanistic links between genes, neurons and a conserved mammalian behavior essential for early life health in rodents and humans alike.
Columbia University
Appointed in 1984
Approaches to isolating a gene encoding a mammalian serotonin receptor
Yale University
Appointed in 2025
Uncovering the principles of immune sensing within the central nervous system
Dr. Madeleine Junkins is intrigued by brain-body interactions and how this relationship enables complex behaviors and functions. During her graduate research she investigated thirst suppression in ground squirrels, a hibernating species that can forgo water for months. During her fellowship, Junkins will interrogate collaborative immune-neural responses to illness.
During her thesis research in Dr. Elena Gracheva’s lab at Yale University, Junkins demonstrated that a specialized subset of neurons are activated at low temperatures during hibernation and promotes the release of a hormone that tells the body to hold onto water. Additionally, she found that thirst-sensing neurons in specialized brain areas called the circumventricular organs are functionally suppressed during hibernation. Collectively, Junkins’ research provided a major leap forward for understanding the neural regulation of thirst suppression during hibernation.
As a postdoc in Dr. Ruslan Medzhitov’s lab at Yale, Dr. Junkins will now study how our immune and neural systems collaborate to engage defenses when we’re sick. She will uncover the molecular and cellular components that transform inflammatory signals into neural activity. By manipulating the communication between the immune and neural systems during inflammation, Junkins will provide insight into how these two major body systems interact. This understanding could lead to the identification of novel therapeutic targets for neuroimmune disorders.
Yale University
Appointed in 1987
Role of a Ras-like protein in yeast secretion
National Jewish Center for Immunology and Respiratory Medicine
Appointed in 1994
Read more
National Jewish Center for Immunology and Respiratory Medicine
Appointed in 1994
Role of c-rel in development and gene expression
Harvard University
Appointed in 1966
Structure of ribosomes
University of Washington
Appointed in 2025
Read more
University of Washington
Appointed in 2025
Investigation of immune systems in multicellular bacteria
Dr. Shoshanna Kahne is interested in bacterial pathways and determining how they change in response to their environment. From Mycobacterium tuberculosis to cyanobacteria, Kahne’s research is creating powerful insights with implications ranging from human disease to environmental impacts.
Kahne’s Ph.D. research in Dr. Heran Darwin’s lab at NYU focused on how proteins are marked for breakdown in the bacteria that causes tuberculosis, Mycobacterium tuberculosis. Kahne discovered a protein that regulates marking an important vitamin-making enzyme for degradation in response to the abundance of the vitamin it helps synthesize. Her findings could help identify new ways to treat this deadly disease.
Now, in Dr. Alex Meeske’s lab at the University of Washington, Kahne will study how cyanobacteria defend themselves against infection by viruses. She is investigating species in the order Nostocales and has identified numerous and diverse potential defense systems in their genomes.
Kahne will test Nostocales hosts against diverse viruses to characterize how they succeed or fail to prevent infection. This work may reveal strategies to harness useful qualities of Nostocales, such as their abilities to fix atmospheric carbon and nitrogen, as well as combat their toxic overgrowths which can poison plants, animals, and humans.
Stanford University
Appointed in 2018
Mechanistic dissection of mTOR and autophagy gene function in phagocytosis
Imperial Cancer Research Fund Laboratories, England
Appointed in 1974
Read more
Imperial Cancer Research Fund Laboratories, England
Appointed in 1974
Transformation of human diploid fibroblasts by chemical carcinogens
University of California, San Francisco
Appointed in 2010
Read more
University of California, San Francisco
Appointed in 2010
Genetic interaction mapping and mechanisms of human host cell pathways exploited by endoplasmic reticulum-trafficking toxins
Yale University
Appointed in 1996
Crystallographic studies of DNA-resolvase complexes
University of California, Berkeley
Appointed in 1990
Read more
University of California, Berkeley
Appointed in 1990
Development of a cell-free general recombination system
Brigham and Women's Hospital /
Harvard University Medical School
Appointed in 2011
Read more
Brigham and Women's Hospital / Harvard University Medical School
Appointed in 2011
Elucidation of senescence regulatory networks using unbiased genetic screens
La Jolla Institute for Allergy and Immunology
Appointed in 2012
Read more
La Jolla Institute for Allergy and Immunology
Appointed in 2012
The roles of TETs in pluripotency and early embryogenesis